GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cyfuse Biomedical KK (TSE:4892) » Definitions » Price-to-Operating-Cash-Flow

Cyfuse Biomedical KK (TSE:4892) Price-to-Operating-Cash-Flow : (As of May. 15, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Cyfuse Biomedical KK Price-to-Operating-Cash-Flow?

As of today (2024-05-15), Cyfuse Biomedical KK's share price is 円719.00. Cyfuse Biomedical KK's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was 円0.00. Hence, Cyfuse Biomedical KK's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Cyfuse Biomedical KK's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 4 years, Cyfuse Biomedical KK's highest Price-to-Operating-Cash-Flow Ratio was 6.87. The lowest was 4.03. And the median was 4.96.

TSE:4892's Price-to-Operating-Cash-Flow is not ranked *
in the Drug Manufacturers industry.
Industry Median: 17.46
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Cyfuse Biomedical KK's Cash Flow from Operations per share for the three months ended in Dec. 2023 was 円0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was 円0.00.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -20.50% per year.

During the past 4 years, Cyfuse Biomedical KK's highest 3-Year average Operating Cash Flow per Share Growth Rate was -20.50% per year. The lowest was -20.50% per year. And the median was -20.50% per year.


Cyfuse Biomedical KK Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Cyfuse Biomedical KK's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cyfuse Biomedical KK Price-to-Operating-Cash-Flow Chart

Cyfuse Biomedical KK Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
- - - -

Cyfuse Biomedical KK Quarterly Data
Dec20 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only - - - - -

Competitive Comparison of Cyfuse Biomedical KK's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Cyfuse Biomedical KK's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cyfuse Biomedical KK's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cyfuse Biomedical KK's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Cyfuse Biomedical KK's Price-to-Operating-Cash-Flow falls into.



Cyfuse Biomedical KK Price-to-Operating-Cash-Flow Calculation

Cyfuse Biomedical KK's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=719.00/0
=

Cyfuse Biomedical KK's Share Price of today is 円719.00.
Cyfuse Biomedical KK's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Cyfuse Biomedical KK Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Cyfuse Biomedical KK's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Cyfuse Biomedical KK (TSE:4892) Business Description

Traded in Other Exchanges
N/A
Address
3-5-27, Mita, West Wing-1st Floor. Sumitomo Fudosan Mita Twin Building, Minato-ku, Tokyo, JPN
Cyfuse Biomedical KK is engaged in the development, manufacturing, and sales of regenerative medicine related products.

Cyfuse Biomedical KK (TSE:4892) Headlines

No Headlines